Can omega-6 excess and related genetic variation increase inflammatory eicosanoid tone?

Genetic variations in lipid metabolism and cytokine pathways interact dynamically with dietary fatty acids to alter systemic inflammatory tone and cardiovascular risk.

Biosynthetic pathways and substrate dynamics

• Accelerated desaturation: Genetic variants in FADS1 (such as the rs174537 G allele) enhance delta-5 desaturase activity, accelerating the conversion of omega-6 precursors into arachidonic acid (AA).
• Eicosanoid shift: An elevated AA to eicosapentaenoic acid (EPA) ratio expands the substrate pool for cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. This drives the production of pro-inflammatory mediators like prostaglandin $E_2$ ($PGE_2$) and leukotriene $B_4$ ($LTB_4$), while suppressing the synthesis of anti-inflammatory, pro-resolving mediators like resolvins.

Vascular protection and cytokine amplification

• Rapid epoxide degradation: Vascular-protective and vasodilatory epoxyeicosatrienoic acids (EETs) are highly susceptible to rapid degradation by soluble epoxide hydrolase, encoded by the EPHX2 gene. Enhanced EPHX2 activity compromises this anti-inflammatory defense, leaving blood vessels vulnerable to unchecked inflammatory signals.
• Cytokine feedback loops: Heightened cellular responsiveness to inflammatory signals, such as that seen with the TNF -308A allele, interacts with the lipid cascade. AA-derived eicosanoids act upstream to stimulate cellular production of tumor necrosis factor-alpha (TNF-$\alpha$), establishing a positive feedback loop that amplifies the systemic inflammatory set-point.

Bottom line

• Key takeaway: The convergence of high dietary omega-6 intake with genetic predispositions—specifically hyperactive FADS1 desaturation, accelerated EPHX2-mediated epoxide clearance, and elevated TNF responsiveness—creates a synergistic environment that drives chronic inflammatory tone and severely weakens vascular-protective lipid signaling.